Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Pauwels, Patrick" or (type exact bookEditor and editor="Pauwels, Patrick")

Add to list
- Journal Article
- A1
- open access
Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib

Ahmad Awada, Thierry Berghmans, Paul M. Clement, Kristof Cuppens, Bram De Wilde (UGent) , Jean-Pascal Machiels, Patrick Pauwels, Marc Peeters, Sylvie Rottey (UGent) and Eric Van Cutsem

(2022) CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 169.
Add to list
- Journal Article
- A1
- open access
The use of pan-tropomyosin receptor kinase immunohistochemistry as a screening tool for the detection of neurotrophic tropomyosin-related kinase fusions : real-world data from a national multicentric retrospective study

Mieke R. Van Bockstal, Gabriela Beniuga, Ligia Craciun, David Creytens (UGent) , Franceska Dedeurwaerdere, Philippe Delvenne, Pieter Demetter, Bart De Wiest, Koen Dewinne, Lionel Habran, et al.

(2022) PATHOBIOLOGY. 89(6). p.393-406
Add to list
- Journal Article
- A1
Cusatuzumab for treatment of CD70-positive relapsed or refractory cutaneous T-cell lymphoma

Nicolas Leupin, Pier Luigi Zinzani, Franck Morschhauser, Stephane Dalle, Marie Maerevoet, Jean-Marie Michot, Vincent Ribrag, Fritz Offner (UGent) , Marie Beylot-Barry, Helene Moins-Teisserenc, et al.

(2022) CANCER. 128(5). p.1004-1014
Add to list
- Journal Article
- A1
GSDME and its role in cancer : from behind the scenes to the front of the stage

Elke De Schutter, Lieselot Croes, Joe Ibrahim, Patrick Pauwels, Ken Op de Beeck, Peter Vandenabeele (UGent) and Guy Van Camp

(2021) INTERNATIONAL JOURNAL OF CANCER. 148(12). p.2872-2883
Add to list
- Journal Article
- A2
PIK3CA in breast cancer : a Belgian practical testing guideline

Glenn Broeckx, Aline Hébrant, Nicky D'Haene, Koen Van de Vijver (UGent) , Jacques Van Huysse, Isabelle Vanden Bempt, Philippe Aftimos, Patrick Neven and Patrick Pauwels

(2021) BELGIAN JOURNAL OF MEDICAL ONCOLOGY. 15(6). p.304-314
Add to list
- Journal Article
- A2
Guidelines for the detection of NTRK fusions : a report from the Belgian Molecular Pathology Working Group

Patrick Pauwels, Glenn Broeckx, Franceska Dedeurwaerdere, Christine Galant, Aline Hébrant, Isabelle Vanden Bempt, Koen Van de Vijver (UGent) , Jacques Van Huysse, Birgit Weynand and Nicky D'Haene

(2021) BELGIAN JOURNAL OF MEDICAL ONCOLOGY. 15(3). p.112-116
Add to list
- Journal Article
- A1
- open access
An open‐label, nonrandomized, phase Ib feasibility study of cusatuzumab in patients with nasopharyngeal carcinoma

Astrid De Meulenaere, Tijl Vermassen (UGent) , David Creytens (UGent) , Stijn De Keukeleire (UGent) , Tim Delahaye, Philippe Deron (UGent) , Fréderic Duprez (UGent) , Samson Fung, Patrick Pauwels, Liesbeth Ferdinande (UGent) , et al.

(2021) CTS-CLINICAL AND TRANSLATIONAL SCIENCE. 14(6). p.2300-2313
Add to list
- Journal Article
- A1
- open access
The NHance® mutation-equipped anti-MET antibody ARGX-111 displays increased tissue penetration and anti-tumor activity in advanced cancer patients

Philippe Aftimos, Christian Rolfo, Sylvie Rottey (UGent) , Philippe Barthélémy, Christophe Borg, Keunchil Park, Do-Youn Oh, Sang-We Kim, Natalie De Jonge, Valérie Hanssens, et al.

(2021) BIOMEDICINES. 9(6).
Add to list
- Journal Article
- A1
Next-generation protein analysis in the pathology department

Melek Ahmed, Glenn Broeckx, Geert Baggerman, Karin Schildermans, Patrick Pauwels, Amaryllis H. Van Craenenbroeck and Amélie Dendooven (UGent)

(2020) JOURNAL OF CLINICAL PATHOLOGY. 73(1). p.1-6
Add to list
- Journal Article
- A1
Unveiling a CD70-positive subset of cancer-associated fibroblasts marked by pro-migratory activity and thriving regulatory T cell accumulation

Julie Jacobs, Vanessa Deschoolmeester, Karen Zwaenepoel, Tal Flieswasser, Christophe Deben, Jolien Van den Bossche, Christophe Hermans, Christian Rolfo, Marc Peeters, Olivier De Wever (UGent) , et al.

(2018) ONCOIMMUNOLOGY. 7(7).
Add to list
- Conference Paper
- C3
Effects of molecular tumor board and different NGS panels implementation for the treatment of patients with cancer

Christian Diego Rolfo, Paolo Manca, Roberto Salgado, Peter Van Dam, Amélie Dendooven (UGent) , Andreia Machado Coelho, Ferri Pep, Annemie Rutten, Willem Lybaert, Joanna Vermeij, et al.

(2018) JOURNAL OF CLINICAL ONCOLOGY. In Journal of Clinical Oncology 36(15, Supplement S).
Add to list
- Journal Article
- A1
- open access
Multidisciplinary molecular tumour board : a tool to improve clinical practice and selection accrual for clinical trials in patients with cancer

Christian Rolfo, Paolo Manca, Roberto Salgado, Peter Van Dam, Amélie Dendooven (UGent) , Andreia Machado Coelho, Jose Ferri Gandia, Annemie Rutten, Willem Lybaert, Joanna Vermeij, et al.

(2018) ESMO OPEN. 3(5).
Add to list
- Journal Article
- A1
Radiotherapy-activated cancer-associated fibroblasts promote tumor progression through paracrine IGF1R activation

Joke Tommelein (UGent) , Elly De Vlieghere (UGent) , Laurine Verset, Elodie Melsens, Justine Leenders, Benedicte Descamps (UGent) , Annelies Debucquoy, Christian Vanhove (UGent) , Patrick Pauwels (UGent) , Christian P Gespach, et al.

(2018) CANCER RESEARCH. 78(3). p.659-670
Add to list
- Conference Paper
- C3
Argx-110 for treatment of CD70-positive advanced cutaneous T-cell lymphoma in a phase 1/2 clinical trial

Martine Bagot, Marie Maerevoet, Pier Luigi Zinzani, Fritz Offner (UGent) , Franck Morschhauser, Jean-Marie Michot, Vincent Ribrag, Maxime Battistella, Helene Moins, Angelica Calleri, et al.

(2018) BLOOD. 132(suppl. 1).
Add to list
- Journal Article
- A1
CD70 and PD-L1 in anaplastic thyroid cancer : promising targets for immunotherapy

Karen Zwaenepoel, Julie Jacobs, Astrid De Meulenaere, Karen Silence, Evelien Smits, Vasiliki Siozopoulou, Esther Hauben, Christian Rolfo, Sylvie Rottey (UGent) and Patrick Pauwels

(2017) HISTOPATHOLOGY. 71(3). p.357-365
Add to list
- Journal Article
- A1
- open access
Preclinical data on the combination of cisplatin and anti-CD70 therapy in non-small cell lung cancer as an excellent match in the era of combination therapy

Julie Jacobs, Vanessa Deschoolmeester, Christian Rolfo, Karen Zwaenepoel, Jolien Van den Bossche, Christophe Deben, Karen Silence, Hans de Haard, Christophe Hermans, Sylvie Rottey (UGent) , et al.

(2017) ONCOTARGET. 8(43). p.74058-74067
Add to list
- Conference Paper
- C3
Clinical response observed in a phase I study in T cell lymphoma patients treated with anti-CD70 SIMPLE antibody ARGX-110

Jean-Marie Michot, Marie Maerevoet, Philippe Georges Aftimos, Sylvie Rottey (UGent) , Christian Diego Rolfo, Fritz Offner (UGent) , Luc Van Rompaey, Mahan Moshir, Hans de Haard, Karen Silence, et al.

(2016) JOURNAL OF CLINICAL ONCOLOGY. 34(15, suppl.).
Add to list
- Journal Article
- A1
Targeting immune checkpoints: new opportunity for mesothelioma treatment?

Elly Marcq, Patrick Pauwels, Jan Van Meerbeeck (UGent) and Evelien LJ Smits

(2015) CANCER TREATMENT REVIEWS. 41(10). p.914-924
Add to list
- Journal Article
- A1
- open access
The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer

Christophe Deben, An Wouters, Ken Op de Beeck, Jolien van den Bossche, Julie Jacobs, Karen Zwaenepoel, Marc Peeters, Jan Van Meerbeeck (UGent) , Filip Lardon, Christian Rolfo, et al.

(2015) ONCOTARGET. 6(26). p.22666-22679
Add to list
- Journal Article
- A1
What can platinum offer yet in the treatment of PS2 NSCLC patients?: a systematic review and meta-analysis

Giuseppe Bronte, Christian Rolfo, Francesco Passiglia, Sergio Rizzo, Ignacio Gil-Bazo, Eugenio Fiorentino, Massimo Cajozzo, Jan Van Meerbeeck (UGent) , Cosimo Lequaglie, Daniele Santini, et al.

(2015) CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 95(3). p.306-317

Academic Bibliography

Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib

The use of pan-tropomyosin receptor kinase immunohistochemistry as a screening tool for the detection of neurotrophic tropomyosin-related kinase fusions : real-world data from a national multicentric retrospective study

Cusatuzumab for treatment of CD70-positive relapsed or refractory cutaneous T-cell lymphoma

GSDME and its role in cancer : from behind the scenes to the front of the stage

PIK3CA in breast cancer : a Belgian practical testing guideline

Guidelines for the detection of NTRK fusions : a report from the Belgian Molecular Pathology Working Group

An open‐label, nonrandomized, phase Ib feasibility study of cusatuzumab in patients with nasopharyngeal carcinoma

The NHance® mutation-equipped anti-MET antibody ARGX-111 displays increased tissue penetration and anti-tumor activity in advanced cancer patients

Next-generation protein analysis in the pathology department

Unveiling a CD70-positive subset of cancer-associated fibroblasts marked by pro-migratory activity and thriving regulatory T cell accumulation

Effects of molecular tumor board and different NGS panels implementation for the treatment of patients with cancer

Multidisciplinary molecular tumour board : a tool to improve clinical practice and selection accrual for clinical trials in patients with cancer

Radiotherapy-activated cancer-associated fibroblasts promote tumor progression through paracrine IGF1R activation

Argx-110 for treatment of CD70-positive advanced cutaneous T-cell lymphoma in a phase 1/2 clinical trial

CD70 and PD-L1 in anaplastic thyroid cancer : promising targets for immunotherapy

Preclinical data on the combination of cisplatin and anti-CD70 therapy in non-small cell lung cancer as an excellent match in the era of combination therapy

Clinical response observed in a phase I study in T cell lymphoma patients treated with anti-CD70 SIMPLE antibody ARGX-110

Targeting immune checkpoints: new opportunity for mesothelioma treatment?

The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer

What can platinum offer yet in the treatment of PS2 NSCLC patients?: a systematic review and meta-analysis

Contents

Support

Contact